Impax Laboratories Inc
Julie Daves is a seasoned professional in the pharmaceutical industry with a career spanning over 15 years. Currently serving as the Senior Regional Business Manager for South Central at Amneal Pharmaceuticals since March 2018, Julie has a history of driving sales and building relationships, having previously held positions as Regional Business Manager and Senior Specialty Sales Representative at Impax Laboratories since March 2014. Notably, Julie is a national sales award winner recognized for selling innovative technologies to improve patient outcomes. Prior experience includes serving as a Senior Sales Consultant at Novartis from March 2008 to February 2014, where Julie specialized in calling on various healthcare facilities and specialists. Julie Daves holds a degree from Texas A&M University, earned between 1994 and 1997.
This person is not in any teams
This person is not in any offices
Impax Laboratories Inc
Impax Laboratories, Inc. is a specialty pharmaceutical company. The Company is engaged in the development, manufacture and marketing of bioequivalent pharmaceutical products (generics), in addition to the development and marketing of branded products. Its segments include Impax Generics and Impax Specialty Pharma. The Impax Generics segment is focused on the development, manufacture, sale and distribution of its generic products, which are the pharmaceutical and therapeutic equivalents of brand-name drug products and are marketed under their established drug names. The Impax Specialty Pharma segment is engaged in the promotion, sale and distribution of several branded products, including its branded pharmaceutical product, Rytary, an extended release oral capsule formulation of carbidopa-levodopa for the treatment of Parkinson's disease, post-encephalitic Parkinsonism and Parkinsonism, and Zomig (zolmitriptan) products, indicated for the treatment of migraine headaches.